Suggestions
Ilya Gluhovsky
Founder and CEO of Areti Health
Ilya Gluhovsky is a prominent technology executive and the Co-Founder and CEO of Areti Health, a company specializing in generative AI solutions for healthcare. He has over 23 years of extensive experience in various areas, including software engineering, data science, machine learning, and entrepreneurship. His educational background includes a Ph.D. in Statistics from Stanford University and a B.S. in Honors Math with Highest Distinction from Purdue University.
Throughout his career, Gluhovsky has held significant leadership roles in several organizations, including:
- Chief Technology Officer at Uprise Health: He was responsible for technological strategy and execution.
- Chief Technology Officer at Pear Therapeutics: Led the development of FDA-regulated digital therapeutics.
- Chief Scientist at Ancestry.com: Built and managed the data science team, enhancing user experience metrics.
- Senior roles at companies like LeanTaaS, Rally Health, and Digg: Contributed to various technological advancements and innovations.
Gluhovsky has also published 17 professional journal articles and holds 22 patents, showcasing his contributions to the field. His work at Areti Health focuses on improving customer acquisition through AI-driven solutions that enhance user engagement and operational efficiency.12
Highlights
Great ambience at the $70M AGI House (AGI = artificial general intelligence) Hillsborough mansion over the weekend hackathon. Alexander Ratner mentioned how most of "innovation team" projects become cool demos and never reach production. He explained the difference between simple AI-out-of-the-box prototypes and bespoke/complex use cases requiring production accuracy, where a real development effort is required, same as for any enterprise product. This made me think back to a few posts I recently saw, where people say the most popular programming language is (or is soon to be) English. When I hear this, I am always thinking back to all the python code we are writing just so that this "English" could work reliably. When we talk to our prospective customers, we get anything from "why do I need you, this is just like ChatGPT" to "I don't think AI is ready for prime time, don't you hear about all the hallucinations?" In Alex's words, Some use cases will work out of the box, but the hardest and most value-aligned will not. Well, just as in any complex product with multiple use cases, for our clinical trial recruitment assistant it is all about leveraging its unique data and characteristics, deep domain expertise, listening to customer needs and pain points, and custom tooling including guardrails and observability. Oh and AI or not, we still need to bi-directionally integrate into customers' processes and tools or they won't think it's magic!
Attending the World Vaccine Congress Washington 2024 on April 1-4 in D.C.? Please stop by our Booth S56 to explore our generative AI-driven clinical trial participant recruitment and patient enrollment solution that dramatically boosts your social media and provider referral conversion rates (63% over 100+ studies)
https://lnkd.in/gKypBxtt
#WVCDC #WorldVaccineCongress
